Breast Cancer Screening in the United Arab Emirates: Is it Time to Call for a Screening at an Earlier Age?
Journal Title: Open Access Journal of Oncology and Medicine - Year 2018, Vol 2, Issue 2
Abstract
Cancer is a major health issue around the world, in the United Arab Emirates ( UAE ) it is the 3rd leading cause of death after cardiovascular diseases and injuries, accounting for 10% of all mortalities in the UAE in 2010 [1] and 16% of all mortalities in the Emirate of Abu Dhabi in 2015 [2]. Breast cancer (BC) is the most frequent cancer in females among UAE citizens (32.16%) as well as Non- UAE citizens (41.41%) [3]. Females in the UAE has the tendency to develop BC at least a decade earlier than their counterparts in western countries [3-5]. The UAE government has made strident efforts to promote early cancer detection through different health authorities in the UAE. The Health Authority of Abu Dhabi (The UAE’s largest health district) began to have screening programs for colorectal, breast, and cervical cancers in 2008 [6]. Dubai Health Authority (the second-largest health district in UAE) introduced breast, cervical, and colon cancer screening in 2014 [7]. In September 2015 [8], the Ministry of Health (covering the rest of the UAE health districts) launched an official cancer screening initiative, to raise awareness about cancer and about the importance of early detection through regular medical checkups for colorectal, breast, and cervical cancers [8,9] All the abovementioned screening efforts were aligned with the North American and European international guidelines regarding the age of onset and the frequency of screening of different cancers, including breast cancer screening [10,11]. Mammography screening every 2 years has shown the greatest mortality reduction benefit in the age group of 50–69 years, and it is recommended by the European Union and numerous individual countries [12].
Authors and Affiliations
Humaid O Al Shamsi, Sadir Alrawi
Keywords
Related Articles
- EP ID EP589063
- DOI 10.32474/OAJOM.2018.02.000131
- Views 75
- Downloads 0
Permissiveness Paradox in Cell Cycle Progression Towards Genome Instability and Malignant Transformation
Dimensional representation of events actively executing the cell cycle dynamics of progression in carcinogenesis allow for a paradoxical emergence of highly permissive elements in the establishment of the mitotic spindle...
Metformin Treatment Represses Vascular Endothelial Growth Factor Gene Transcription in MCF-7 Breast Cancer Cells
Background/Aim:Targeting angiogenesis preferentially in cancer is a promising approach to improve treatment efficacy and safety. The aim of this study is investigate potential upregulation of Krüppel like factor-4(KLF-4)...
Breast Cancer Screening in the United Arab Emirates: Is it Time to Call for a Screening at an Earlier Age?
Cancer is a major health issue around the world, in the United Arab Emirates ( UAE ) it is the 3rd leading cause of death after cardiovascular diseases and injuries, accounting for 10% of all mortalities in the UAE in 20...
Use of Umblical Cord Blood in the Management of Leukaemia
Leukaemia is a blood disorder caused by uncontrolled production and release of abnormal blasts cells in the bone marrow and in the circulation. Treatment of leukaemia has been a great challenge and many patients die. The...
Acute Erythroblastic Leukemia Revealed by Dermatological Manifestations
Acute erythroblastic leukemia is characterized by the proliferation of a predominant erythrocyte population on other lineages. Cutaneous manifestations remain rare and misleading, making the diagnosis of difficult to sus...